An observational study in Knee Osteoarthritis, sponsored by Dijklander Ziekenhuis. Recruiting at 1 site in Netherlands. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2023-12-18.
Sponsored by Dijklander Ziekenhuis · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Osteoarthritis, Knee with a site in Netherlands — 9 open to participants now, 11 under way, 1 of them phase 3. Osteoarthritis, Knee · Netherlands.
Among the 32 studies in Osteoarthritis, Knee with a site in Netherlands, this one is the 5th largest by planned enrollment of the 11 observational ones that give a count, is one of 2 that started in 2023, is one of 11 observational ones, reaches primary completion later than 3 of the 10 other live ones, and was the 27th registered.
3,295 studies on the registry are indexed under Osteoarthritis, Knee; 624 are open to participants now.
Browse Osteoarthritis, Knee studies →9 of the 32 studies in Osteoarthritis, Knee with a site in Netherlands are open now. Recruiting first, the newest first:
UMC Utrecht · Sites in Netherlands
Ages 45+
Mariette Boshuis · Sites in Netherlands
Ages 18+
Next Biomedical Co., Ltd. · Sites in Netherlands, Belgium
Ages 50+
Sint Maartenskliniek · Sites in Netherlands
Ages 45–80
Ziekenhuis Oost-Limburg · Sites in Netherlands, Belgium
Ages 18+
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 383 Osteoarthritis, Knee studies recruiting now, 177 (46%) set no upper age limit and 113 (30%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 150 is above the median of 100 across 486 observational studies indexed under Osteoarthritis, Knee.
Median enrollment 72 across the 21 interventional studies, 100 across the 11 observational. Of the 18 that completed or were terminated, 7 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 32 have an industry lead sponsor. The 10 most frequent:
Dijklander Ziekenhuis is the lead sponsor of 7 studies on the registry; 3 are open to participants now.
Dijklander Ziekenhuis has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
4 of the studies in Osteoarthritis, Knee with a site in Netherlands that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06127719Dijklander ZiekenhuisThe Effects of Surgical Wait Time for Knee Arthroplasty Quality of Life in Patients Awaiting Knee Arthroplasty | 2026-12 |
| NCT07423858UMC UtrechtPredicting The Right Advice at The Right Time in Patients With Hip and Knee OsteoArthritis: the e-cOAch Cross-over. | 2027-02 |
| NCT06930677Next Biomedical Co., Ltd.Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200 | 2027-02 |
| NCT07845838Mariette BoshuisThe Effect of Training on Oxidative Stress in Patients With kneeOA. | 2027-06-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 32 studies in Osteoarthritis, Knee with a site in Netherlands, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study prospectively evaluates the effect of surgical wait time on knee function, pain and quality of life in patients waiting for knee arthroplasty (TKA or PKA)
Osteoarthritis (OA) is a common condition, leading to pain and disability. The knee is the most affected joint, accounting for almost 80 percent of the total prevalence of OA. The pooled global prevalence of knee OA is 22.9% in individuals aged 40 and over. Correspondingly, there are around 654.1 million individuals with knee OA in 2020 worldwide. The number of people affected with symptomatic knee OA is likely to increase because of the aging population and the obesity epidemic.
Pain is the most important symptom in knee OA. It is intermittent, typically weight bearing and progressive over time. Additional symptoms are crepitus, swelling and morning stiffness. The knee is often swollen and has diminished range of motion (ROM). Not only does OA lead to functional disability, but also influences social participation and quality of life.
Knee OA is a progressive disease, which requires continuous management. Treatment consists of conservative as well as invasive treatments, as described in national and international guidelines. First line treatments are patient education, physical therapy, weight loss, different pharmacological treatments and intra-articular steroid injections. More advanced OA may require surgery. Knee arthroplasty, (total knee arthroplasty (TKA) or partial knee arthroplasty (PKA)) can provide excellent pain relief, remarkable deformity correction, and satisfactory functional recovery.
Since the beginning of the covid19 pandemic, surgeons have been asked to only perform essential surgeries in order to preserve healthcare resources. This has led to an increase in patients on the waiting list, resulting in unusually high wait times. Despite the decrease in covid related healthcare consumption, waiting times are yet to return to pre-covid duration. Currently, time to surgery in our hospital is approximately 7 months as opposed to 2-3 months pre-covid.
Long wait times may be a substantial burden for patients. There have been reports of worsening pain, deterioration in quality of life and increased opioid use and frailty. The effects on pain catastrophizing, fear and anxiety have not yet been studied.
It is important to better understand the effects of long surgical wait times on pre-operative knee function, pain and quality of life as well as to investigate how this effects outcome after surgery.
The study population consists of adult patients on the waiting list for knee arthroplasty (TKA or PKA).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
adult patient on the waiting list for knee arthroplasty
Other: questionnaires
before surgery, patients are asked to fill out the questionnaires as stated in the outcome measures paragraph
Knee function measured with the Oxford knee score (OKS)
This questionnaire consists of 12 items, which are divided into disease-specific and generic questions. Scores can range from 0 - 48, lower scores indicate more functional limitations and pain.
Time frame: Baseline, before surgery
numeric rating scale for pain (NRS)
This scale consists of 11 numbers from 0-10, where 0 means no pain at all and 10 is the most pain imaginable. The patient should circle the number that best represents the severity of pain experienced over the past week
Time frame: baseline, before surgery, 6 and 12 months postoperatively
Health related quality of life with the euroqol 5 dimensions (EQ-5D-5L)
The EQ-5D is a questionnaire that scores five health dimensions (mobility, self-care, daily activities, pain/discomfort and anxiety/depression). Patient must indicate their health status: no problems, slight problems, moderate problems, severe problems, extreme problems.
Time frame: baseline, before surgery, 6 and 12 months postoperatively
Hospital anxiety and depression scale (HADS)
This is a short questionnaire that is easy to use. The scale examines feelings in the past week and consists of an anxiety scale and a depression scale with both 7 items. The higher a patient scores on this questionnaire, the more complaints one experiences.
Time frame: baseline, before surgery, 6 and 12 months postoperatively
Pain catastrophizing scale (PCS)
This self-assessment questionnaire consists of 13 statements that contain a number of thoughts and feelings that one may experience having pain. The items are divided into the categories rumination, magnification and helplessness, with each item scored on a 5-point scale. The sum of scores ranges from 0 - 52, with higher scores indicating higher levels of catastrophizing.
Time frame: baseline, before surgery, 6 and 12 months postoperatively
medical consumption questionnaire (iMCQ)
The iMCQ includes questions related to frequently occurring contacts with health care providers. Reference is made to healthcare consumption due to illness, disability or psychiatric problems, without specifying a particular disease. Healthcare consumption in the preceding 13 weeks is applicable.
Time frame: before surgery
Knee function measured with the Oxford knee score (OKS)
This questionnaire consists of 12 items, which are divided into disease-specific and generic questions. Scores can range from 0 - 48, lower scores indicate more functional limitations and pain.
Time frame: 6 and 12 months postoperatively
Plan to share: Undecided
Started Dec 2023 (actual). Primary completion is estimated for Dec 2026, 36 months after the start.
Of 179 non-industry observational studies under Osteoarthritis, Knee, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 36 months is above that.
Counting every sponsor, half of 220 studies reached it within 24 months; a quarter within 14 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dijklander Ziekenhuis